Anesiva Inc., of South San Francisco, named Ted W. Love and David C. U'Prichard to its board, following completion of the merger with Arcion Therapeutics...CellCyte Genetics Corp., of Eastgate, Wash., appointed Douglas Cerretti chief science officer and director of business development...It also appointed Andrew K. W. Powell executive vice president, general counsel and secretary

Oxygen Biotherapeutics Inc., of Durham, N.C., added Rene A. Eckert and William A. Chatfield to its board...Santaris Pharma A/S, of Horsholm, Denmark, added Mark Wedel as vice president and chief medical officer and Stuart Mackey as vice president of strategy and chief business officer

BioAlliance Pharma SA, of Paris, appointed André Ulmann and Denis Biju-Duval to its supervisory board...BrainCells Inc., of San Diego, appointed Edward Scolnick and David Holtzman to its scientific advisory board...DBV Technologies, of Paris, added Gideon Lack and Philippe Eigenmann to its scientific advisory board

BioAlliance Pharma SA, of Paris, appointed André Ulmann and Denis Biju-Duval to its supervisory board...BrainCells Inc., of San Diego, appointed Edward Scolnick and David Holtzman to its scientific advisory board...DBV Technologies, of Paris, added Gideon Lack and Philippe Eigenmann to its scientific advisory board

RetroVirox Inc., of San Diego, appointed Ronald C. Griffith vice president of research and development...Seaside Therapeutics LLC, of Cambridge, Mass., appointed Daniel E. Geffken chief operating officer, John C. Amedio vice president of manufacturing and process development and W. Roger Rush vice president of preclinical development...XOMA Ltd., of Berkeley, Calif., appointed Susan Kramer vice president, project and alliance management

Apthera Inc., of Scottsdale, Ariz., appointed Ira Z. Leiderman executive chairman and named Mary Ann Gray to the board...Dendreon Corp., of Seattle, elected Ian Clark and Pedro Granadillo to its board...NeoStem Inc., of New York, named Teresa Lepore vice president, sales and marketing

Ocular Therapeutix Inc., of Waltham, Mass., named Daniel Myers and Bernard Haffey to its board...Sigma-Aldrich, of St. Louis, appointed George M. Church a director and named George Miller senior vice president, general counsel and secretary

Micromet Inc., of Bethesda, Md., appointed Jan Fagerberg senior vice president and chief medical officer...MorphoSys AG, of Martinsried, Germany, appointed Lisa Rojkjaer vice president and head of clinical development...and promoted David Dodds to president of Sucampo Pharma Europe Ltd

BioMicro Systems, of Salt Lake City, appointed Rob Parry president and chief operating officer...Ironwood Pharmaceuticals Inc., of Cambridge, Mass., named Thomas McCourt chief commercial officer and senior vice president of marketing and sales, and appointed David Ebersman to its board

Spherix Inc., of Bethesda, Md., named Ram R. Nimmagudda director of new business development. Tethys Bioscience Inc., of Emeryville, Calif., promoted Michael Richey to president. Trinity Biosystems, of Menlo Park, Calif., appointed René Castro chief business officer. Vantia Therapeutics, of Southampton, UK, appointed Andrew Crockett vice president of business development. Vivalis, of Nantes, France, appointed Philippe Rousseau chief financial officer.

AAIPharma Services Corp., of Wilmington, N.C., appointed Christopher Smith vice president of quality and regulatory affairs...Bioheart Inc., of Sunrise, Fla., named Karl E. Groth chairman of the board, Peggy A. Farley chief operating officer and Mark P. Borman chief financial officer...PharmAthene Inc., of Annapolis, Md., appointed Charles A. Reinhart III senior vice president and chief financial officer

Immucor Inc., of Norcross, Ga., named Geoffrey S. Crouse vice president and chief operating officer...Third Rock Ventures LLC, of Boston, appointed Philip R. Reilly and Gregory L. Verdine venture partners, and Craig M. Greaves recruiting partner

Novavax Inc., of Rockville, Md., appointed John J. Trizzino senior vice president of international and government alliances

EGEN Inc., of Huntsville, Ala., promoted Jason Fewell to vice president of preclinical research and development...Nuon Therapeutics Inc., of San Mateo, Calif., appointed Paulette Dillon chief business officer and Tito Serafini chief scientific officer...Xanodyne Pharmaceuticals Inc., of Newport, Ken, appointed Natasha Giordano as chief commercial officer, Rita O'Connor as chief financial & information officer, and Peter Wentworth as senior vice president for human resources

Columbia Laboratories Inc., of Livingston, N.J., appointed Lawrence Gyenes senior vice president, chief financial officer and treasurer...MDRNA Inc., of Bothell, Wash., appointed Peter S. Garcia chief financial officer and secretary

Synta Pharmaceuticals Corp., of Lexington, Mass., appointed Vojo Vukovic senior vice president and chief medical officer

Hollis-Eden Pharmaceuticals Inc., of San Diego, appointed James M. Frincke president and CEO...Oncothyreon Inc., of Seattle, appointed Scott Peterson vice president of research and development...Oxigene Inc., of Waltham, Mass., appointed Peter J. Langecker executive vice president and chief development officer

vice president of finance and administration

Anavex Life Sciences Corp., of Geneva, appointed Hervé de Kergrohen CEO and director...Cadence Pharmaceuticals Inc., of San Diego, named Scott Byrd senior vice president and chief commercial officer